Ruxolitinib Zentiva (ruxolitinib) approved in the EU
Marketing authorisation to Zentiva k.s.; Generic
12 Nov 2026 · European Commission · Approval
Official record: European Commission ↗
Written by CompePharma's editorial system from the official record. AI-assisted; check the source before acting. Not investment advice.
More Approvals & launchesAll →
Approvals & launches
Imricor starts US launch of NorthStar iMR system after paediatric FDA clearances
13 Nov 2026 · Imricor Medical Systems, Inc. · Company news
Approvals & launches
FDA grants NeOnc Type B meeting on accelerated approval path for intranasal NEO100
13 Nov 2026 · Neonc Technologies Holdings, Inc. NTHI · Company news
Approvals & launches
CHMP backs Cosentyx for adolescents aged 12+ with moderate-to-severe hidradenitis suppurativa
13 Nov 2026 · Novartis Pharma AG · Company news
Approvals & launches
TuHURA wins FDA IND clearance for VISTA antibody TBS-2025 in relapsed AML
13 Nov 2026 · TuHURA Biosciences, Inc./NV HURA · Company news
Approvals & launches
CHMP backs Roche's Gazyvaro as add-on therapy for autoantibody-positive lupus
13 Nov 2026 · Roche · Company news
Approvals & launches
CHMP recommends Roche's Gazyvaro as add-on therapy for autoantibody-positive lupus
13 Nov 2026 · F. Hoffmann-La Roche Ltd · Company news